Erasca Inc. Common Stock vs MiniMed Group Inc. Common Stock — how do they compare? Erasca Inc. Common Stock trades at $15.55 (market cap $5.40B), while MiniMed Group Inc. Common Stock trades at $19.57 (market cap $5.57B). The key difference: Erasca Inc. Common Stock and MiniMed Group Inc. Common Stock are close in size by market cap, and MiniMed Group Inc. Common Stock is more actively traded (23,336,073 versus 9,533,185). Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and MiniMed Group Inc. Common Stock for 0 Days on average.
| ERAS | MMED | |
|---|---|---|
Market Cap | $5.40B | $5.57B |
Volume | 9,533,185 | 23,336,073 |
Sector | Health | Health |
52-Week High | $22.47 | $23.84 |
52-Week Low | $2.20 | $10.80 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.18B | $5.37B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →